Latest Global Markets News

Champion Iron Limited has upsized its senior notes offering to US$500 million, pricing the debt at 7.875% interest to refinance existing credit facilities and support ongoing project development.

Alkane Resources has moved forward with its planned merger with Mandalay Resources, scheduling shareholder meetings for late July to approve the deal that would create a diversified Australian-focused gold and antimony producer.

Champion Iron Limited has launched a US$450 million senior notes offering due 2032 to refinance existing debt and support corporate initiatives, signaling strategic financial repositioning.

MA Credit Income Trust (ASX, MA1) has successfully raised nearly A$50 million through a wholesale placement, reflecting strong investor appetite for its private credit strategy. The placement was complemented by a significant sell-down of existing units, underscoring robust demand.

RareX Limited confirms exceptional high-grade gallium mineralisation at its Cummins Range project, positioning it as a strategic critical minerals asset amid soaring global demand and supply risks.

Treasury Wine Estates projects strong fiscal 2025 earnings driven by luxury brands Penfolds and DAOU, while unveiling a new divisional model and a significant share buyback.

Eden Innovations is set to consolidate its shares and launch a $6.6 million entitlement offer to reduce debt and fund global expansion of its EdenCrete® and OptiBlend® products.

Staude Capital Global Value Fund Limited has completed a $16.9 million wholesale placement and opened a Share Purchase Plan for existing shareholders, aiming to deploy capital through its discount capture strategy.

xReality Group is rapidly transforming its business by focusing on its high-growth Operator XR training platform, while preparing to divest legacy entertainment assets. The company reports record revenue and expanding global reach, particularly in the US defence and law enforcement sectors.

Argenica Therapeutics has reported compelling preclinical results for ARG-007, demonstrating sustained neuroprotection and functional recovery in a ferret model of moderate traumatic brain injury. These findings pave the way for clinical trials targeting a major unmet medical need.

Provaris Energy and Yinson have completed the design of a groundbreaking large-scale liquid CO2 tank for maritime use and are forming a joint venture to commercialize this innovation, aiming to scale carbon capture supply chains and reduce costs.

CSL has secured FDA approval for ANDEMBRY®, a pioneering treatment for hereditary angioedema, enabling an immediate US launch with promising clinical results. This milestone marks a significant advance in managing a rare but debilitating condition.